John Huemoeller, CEO of AXIM Biotechnologies, discusses his company’s recently announced COVID-19 test that aims to speed up the COVID testing process that would, hopefully, lead to a COVID-19 vaccine more quickly. Huemoeller chats about AXIM’s pivot into cancer care.
- Home
- Shows
- About
- SchoolCast
- CauseCast
- Case Studies
- Poducation
- Contact
Research and Development Company Addresses COVID-19 Testing and Cancer Care
Podcast: Play in new window | Download
Recent Posts
- Ambassador for Transgender Service Members Shouts out SPARTA Pride
- Children’s Author Bullish on Food Insecurity and World Hunger
- “Full STEAM Ahead” Initiative Exemplifies Collaborative Learning in National City
- Pulitzer Prize Winning Editorial Cartoonist’s Talents Now Showcased at inewsource
- Father Joe’s Villages Relentless in Expanding Services to Prevent and End Homelessness
Recent Comments
- Peter Sibley on Leading Cyber Security Company Works With Vulnerable Organizations to Thwart Cyber Attacks
- Steve White on Local Nonprofit and Real Estate Investment Trust Team Up To Build New Lives for the Homeless
- Judy Reeves on Educator Turned Best-Selling Author Passionate About the Arts
- Robert m Lassiter on Episode 13 | Spy Dawg: Espionage, Football & Music
- Anne Wheeler-Lassiter on Episode 13 | Spy Dawg: Espionage, Football & Music